XCMG Delivers 1,000-Tonne All-Terrain Crane in South Korea, Completes First Bridge Lift
PYEONGTAEK, South Korea, May 8, 2026 /PRNewswire/ -- Recently, Xuzhou Construction Machinery Group (XCMG), a global provider of construction machinery and lifting solutions, delivered its XCA1000G8-1K all-terrain crane to the South Korean market....
Bambusa Therapeutics Completes Patient Enrollment in the Phase 1b/2a Trial Evaluating BBT001 as a Treatment for Atopic Dermatitis
- Bambusa's lead product candidate, BBT001 is a next-generation long-acting bispecific antibody targeting two clinically and commercially validated targets, IL-4Rα and IL-31 for the treatment of atopic dermatitis (AD) and other type 2 inflammatory...
MetaComp Group Completes Tether Gold (XAUT) Proof-of-Concept and Launches Commercial Tokenised Gold Capabilities for Institutional Clients
MetaComp Group validates tokenised gold across three use cases — cross-border payments, long-term value preservation, and gold-collateralised working capital — following a live proof-of-concept that successfully executed a US$10,000 equivalent...
Beyond Simulation: Sungrow Completes World's First Large-Scale Full-Condition Grid-Forming Extreme Test
HEFEI, China, April 28, 2026 /PRNewswire/ -- Sungrow, the globally leading PV inverter and energy storage system provider, successfully completed the world's first large-scale grid-forming full-scenario validation. The program covered 14 scenarios...
"Pretty Messy" Completes Jūji's Debut Album Journey -- A Luminous Title Track About Embracing Pain and Moving Forward
BANGKOK, April 27, 2026 /PRNewswire/ -- Thai indie pop–jazz outfit Jūji gracefully wraps up its debut full-length album with "Pretty Messy," a beautifully crafted title track that invites listeners to embrace past wounds before stepping into the...
Ascletis Completes Enrollment in U.S. Phase II Study of ASC30, an Oral Small Molecule GLP-1R Agonist, for the Treatment of Diabetes
- 13-week U.S. Phase II study is evaluating the efficacy, safety and tolerability of oral small molecule GLP-1R agonist ASC30, a once-daily tablet, in 100 participants with diabetes. - Topline data from the Phase II study are expected in the third...
Safety. For Family: TIGGO9 Completes Public Three-Vehicle Composite Crash Verification During the 2026 International Business Summit
WUHU, China, April 26, 2026 /PRNewswire/ -- In April 2026, during the 2026 International Business Summit, CHERY completed a public three-vehicle composite crash validation of the TIGGO9 at the Chery Crash Safety Laboratory, witnessed on site by...
XCMG Hydrogen-Powered Heavy Truck Completes "Hydrogen Marathon" Verification, Advancing Low-Carbon Heavy Transport
XUZHOU, China, April 22, 2026 /PRNewswire/ -- As Earth Day underscores this year's theme, "Our Power, Our Planet," global momentum toward low-carbon transition continues to accelerate. Against this backdrop, XCMG's hydrogen-powered heavy truck has...
Datasea Intelligent Technology Ltd. Completes Delivery of Three AI Multimodal Solution Projects with Aggregate Contract Value of Approximately USD 1.01 Million
Completed Projects Further Support the Company's Transition Toward High-Margin, Solution-Driven Revenue and Strengthen Customer Stickiness Across AI Multimodal Application Scenarios BEIJING, April 20, 2026 /PRNewswire/ -- Datasea Intelligent...
AutoFlight Completes First 2-Ton-Class eVTOL Tea Delivery in China
KUNSHAN, China, April 17, 2026 /PRNewswire/ -- AUTOFLIGHT has successfully completed China's first 2-ton-class eVTOL dedicated spring tea transport trial in Guizhou, a mountainous province in western China. The trial deployed AutoFlight's CarryAll...